ASCO checkpoint inhibitor battle between Merck and Roche highlights the pitfalls in directly comparing clinical trial results in the era of precision medicine.
Oncology is the most advanced area in genomics right now. The field is setting the standard for other indications to follow and improve upon.
With artificial intelligence, machines can now examine thousands of medical images for signs of disease. Will this technology replace doctors – or work side by side with them?
Scientists have long thought that regions of DNA called telomeres control how long you live. We are now learning that it is your diet and lifestyle that shape your telomeres, not the other way around.
A team of tiny molecules that work together to make cancer cells less aggressive has been discovered by Australian researchers.
Researchers at the Weizmann Institute of Science, in collaboration with physicians, have conducted a study in mice, in which they used existing drugs in a new combination to help crush potential resistance to treatment.
Researchers at the University of Oulu in Finland have discovered novel genes and mechanisms that can explain how a genomic variant in a single nucleotide polymorphism (SNP) rs11672691 influences prostate cancer aggressiveness.
Melanoma is it’s treatable if caught early enough. And a new blood test might be able to help with faster and easier diagnosis. Here’s what has to happen for the test to reach clinics:
Natural selection shapes genomes to evolve and to adapt but, are the rules of natural selection also applying to cancer genome evolution? Researchers suggest negative selection acting on cancer-essential genes plays a more important role than previously anticipated.
Scientists have published one of the most detailed maps ever made of structural variations in a cancer cell’s genome.
Scientists have developed a technique that shows individual cancer cells in a tumour in real-time, revealing which cells that interact with a drug and which cells the drug fails to reach.